The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX‐2 Endowed with Anti‐Aggregatory and Vasodilating Activities

Keywords

Nice, Psychological intervention, Audit, Overweight, Promotion (chess)

References

• Selective inhibitors of cyclooxygenase-2 (COX-2).John J. Talley — 1999
• The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.Marek W. Radomski, Richard Palmer, Salvador Moncada — 1987
• Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rulesThomas A. Halgren — 1996
• Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapyJane A. Mitchell, Timothy D. Warner — 1999
• A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors.Chun-Sing Li, W. Cameron Black, Christine Brideau — 1999
• COX‐2 and cancer: a new approach to an old problemY.S. Bakhle — 2001
• Some heterocyclic sulfonyl derivativesRichard J. Cremlyn, F. J. SWINBOURNE, O. O. Shode — 1985
• FDA public health advisory.Murray Lumpkin — 1998
• Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.Carlos Velázquez, Praveen P. N. Rao, Robert McDonald — 2005
• Cyclooxygenase inhibition and thrombogenicity.Francesca Catella-Lawson, Leslie J. Crofford — 2001
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorRichard Palmer, Anthony G. Ferrige, Salvador Moncada — 1987
• Aminofuroxane. 1. Synthese und StrukturAndré R. Gagneux, René Meier — 1970
• Colored indicators for simple direct titration of magnesium and lithium reagentsSpencer C. Watson, Jerome F. Eastham — 1967
• Risk of cardiovascular events associated with selective COX-2 inhibitors.Debabrata Mukherjee — 2001
• Water soluble furoxan derivatives as NO prodrugs.Giovanni Sorba, Claudio Medana, Roberta Fruttero — 1997
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsRavi G. Kurumbail, Anna M. Stevens, James K. Gierse — 1996
• Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw — 1997
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.Uttam Garg, Aviv Hassid — 1989
• Flexible docking using tabu search and an empirical estimate of binding affinityCarol A. Baxter, Christopher W. Murray, David E. Clark — 1998
• Unsymmetrically substituted furoxans. VII. A 13C NMR study of a series of isomeric pairs of furoxans and the structure of the two isomeric chloro‐phenyl‐furoxansR. CALVINO, Roberta Fruttero, Alberto Gasco — 1982

Cited by

• Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism.Inès Hammami, Marie Bertrand, Jingkui Chen — 2012
• Étude métabolique des cellules myéloïdes suppressives dans le contexte du phénomène d'immunosuppressionIness Hammami — 2011
• Optimisation du concept d'inhibition de Cyclooxygénase dans le traitement du cancer de la prostateNicolas Bézière — 2008
• Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment.Andrew Nortcliffe, Alexander Ekström, James R. Black — 2014
• NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties.Konstantin Chegaev, Loretta Lazzarato, Paolo Tosco — 2007
• An exploration of the mechanisms for the formation of 3,4-bis(4-aminofurazan-3-yl)-furoxan by density functional theoryKun Yang, Xiaofang Chen, Weipeng Lai — 2012
• Mechanistic studies of copper(II)-mediated oxidation of vic-dioxime to furoxanOindrila Das, Tapan Kanti Paine — 2012
• Novel amino acids: synthesis of furoxan and sydnonimine containing amino acids and peptides as potential nitric oxide releasing motifs.Andrew Nortcliffe, Nigel P. Botting, David O’Hagan — 2013
• Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.Francesca Bozzo, Andrea Bassignana, Loretta Lazzarato — 2009
• Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell linesClaudia Bocca, Francesca Bozzo, Andrea Bassignana — 2011
• Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents.Konstantin Chegaev, Loretta Lazzarato, Yasinalli Tamboli — 2014
• Nitrooxymethyl‐Substituted Analogues of Rofecoxib: Synthesis and Pharmacological CharacterizationDonatella Boschi, Clara Cena, Antonella Di Stilo — 2009
• PLANEJAMENTO, SÍNTESE E AVALIAÇÃO FARMACOLÓGICA DE NOVOS COMPOSTOS 1,2,5-OXADIAZOL-2-N-ÓXIDO ÚTEIS COMO PREVENTIVOS DE ATEROTROMBOSEJúlio de Mesquita Filho — 2013
• Design of hybrid heterocyclic systems with a furoxanylpyridine core via tandem hetero-Diels–Alder/retro-Diels–Alder reactions of (1,2,4-triazin-3-yl)furoxansЛеонид Л. Ферштат, Alexander А. Larin, Маргарита А. Епишина — 2016
• Copper(II)-mediated oxidative transformation of vic-dioxime to furoxan: evidence for a copper(II)-dinitrosoalkene intermediate.Oindrila Das, Sayantan Paria, Ennio Zangrando — 2011
• A Series of COX‐2 Inhibitors Endowed with NO‐Releasing Properties: Synthesis, Biological Evaluation, and Docking AnalysisSara Consalvi, Giovanna Poce, Rino Ragno — 2016
• Synthesis of Furoxans (1,2,5‐oxadiazole 2‐oxides) from Styrenes and Nitrosonium Tetrafluoroborate in Non‐Acidic Media and Mechanistic StudyRyosuke Matsubara, Akihiro Ando, Yuta Saeki — 2016
• “Hole-catalyzed” cycloadditions of the gaseous ionized nitrile N -oxides Ph-C N + O and CH 3 C N + O with model dipolarophilesLuiz Alberto Beraldo de Moraes, Paulo Sérgio de Carvalho, Rodinei Augusti — 2017
• Synthesis of alkynyl furoxans. Rare carbon-carbon bond-forming reaction on a furoxan ring.Ryosuke Matsubara, Shuhei Eguchi, Akihiro Ando — 2017
• Synthesis of cyanofuroxans from 4-nitrofuroxans via C-C bond forming reactionsRyosuke Matsubara, Akihiro Ando, Masahiko Hayashi — 2017

Related papers

• WATCH IT: Obesity management for children: A qualitative exploration of the views of parentsRachael Dixey, Mary Rudolf, Joe Murtagh — 2006
• The importance of parents in the lives of children in the care systemJane Thomson, Rosamund Thorpe — 2003
• Decision-Making by Children and Young People in the Home: The Nurture of Trust, Participation and IndependenceShirley Martin, Catherine Forde, Deirdre Horgan — 2018
• Evaluation of NHS Grampian's child healthy weight programmes: Engagement and impactFlora Douglas, L. C. A. Craig, Julia Clark — 2012
• The participation of parents of disabled children and young people in health and social care decisionsPatricia McNeilly, Geraldine Macdonald, Berni Kelly — 2017
• Parents' views of moves towards independence by their adolescent and young adult offspring with learning disabilitiesHelen Turner — 2002
• Parenting Matters: Supporting Parents of Children Ages 0-8Youth Board on Children, Families, Heather Breiner — 2016
• Displaying parental responsibility for childhood obesity: aspects of care and family relationshipsPetra Roll Bennet, Helena Bergström — 2015
• Children's, Young People's and Parents' Perspectives on Contact: Findings from the Evaluation of Social Work PracticesCath Larkins, Julie Ridley, Nicola Farrelly — 2015